The US and EU need time to agree assessments under MRA (mutual recognition agreement)
This article was originally published in Clinica
The mutual recognition agreement (MRA) between the EU and US on medical devices will need the three-year confidence building period for all parties to become familiar with the various practices in each other's territories.
You may also be interested in...
Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.
Managing partner Corey Goodman said venBio didn’t have trouble closing its fund, because the venture capital firm prepared its investors for an economic downturn months ago.
The US FDA has proposed moving two categories of hepatitis C diagnostics to class II from class III because they pose relatively low risk.